Харківська Міська Клінічна Психіатрична Лікарня N 15
Харьковская Городская Клиническая Психиатрическая Больница N 15
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Міська Клінічна Психіатрична Лікарня N 15, Харьковская Городская Клиническая Психиатрическая Больница N 15filedCriticalХарківська Міська Клінічна Психіатрична Лікарня N 15
Priority to UA99010065ApriorityCriticalpatent/UA33191A/en
Publication of UA33191ApublicationCriticalpatent/UA33191A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
In 4 h after the oral administration of Haloperidol and Amitriptyline in the morning in the setting of preceding two-week oral administration, the transorbital electrophoresis of 0.5% Haloperidol solution and 1% Amitriptyline solution is performed for 25-30 minutes using two different ocular electrodes with the increment of the current from 2 to 4 mA, the current density from 0.03 to 0.05 mA/cm2, the course of the treatment comprises 15 daily procedures.
UA99010065A1999-01-051999-01-05Method for treatment of depressive-paranoid syndrome in schizophrenia patients
UA33191A
(en)